1-3 of 3
Jooeun Bae, Ph.D.
Close
Sort by
Journal Articles

Novel Myeloma-Specific Multiple Peptides Able to Generate Cytotoxic T Lymphocytes: Potential Therapeutic Application in Multiple Myeloma and Other Plasma Cell Disorders,

Jooeun Bae, Ph.D., Ruben Carrasco, MD, PhD, Ann-Hwee Lee, Ph.D., Rao Prabhala, Ph.D., Yu-Tzu Tai, PhD, Weihua Song, MD, Kenneth C Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2011) 118 (21): 3990.
https://doi.org/10.1182/blood.V118.21.3990.3990
Published: 2011
Journal Articles

The Polycomb Group Transcriptional Repressor Bmi-1 Is Constitutively Expressed in Multiple Myeloma (MM) Cells and Modulates Proliferation through a Mechanism Independent of the Ink4a/ARF Locus.

Frank J. Desarnaud, Ph.D, Masood Shammas, Ph.D, Paola Neri, MD, Hemanta Koley, Ph.D, Rao Prabhala, Ph.D, Li Cheng, Ph.D, Suk Kim Ryung, Dharminder Chauhan, Ph.D, Pierfrancesco Tassone, MD, Jooeun Bae, Ph.D, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD
Journal: Blood
Blood (2004) 104 (11): 3346.
https://doi.org/10.1182/blood.V104.11.3346.3346
Published: 2004
Journal Articles

Induction of Multiple Myeloma-Specific Cytotoxic T Lymphocytes Using HLA-A2.1-Specific CD19 and CD20 Peptides.

Jooeun Bae, Ph.D., Jeff A. Martinson, B.S., Hans G. Klingemann, M.D., Steven Treon, M.D., Kenneth C. Anderson, M.D., Nikhil C. Munshi, M.D.
Journal: Blood
Blood (2004) 104 (11): 2477.
https://doi.org/10.1182/blood.V104.11.2477.2477
Published: 2004